Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Mankind Pharma

Tracked across 3 events · 19 articles · First seen Mar 20, 2025 · Last active Aug 20, 2026

Sentiment
27
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 30
Business
Impact: Mankind Pharma is the licensee and will commercialize the insulin analogues in India, strengthening its diabetes portfolio and injectable segment. The deal is expected to enhance its market position and revenue potential.
Aug 20, 2026 · 6 articles
4 50
Regulatory
Impact: Arjun Juneja, COO of Mankind Pharma, highlighted India's strong pharmaceutical base and the need for collaboration.
Apr 12, 2026 · 6 articles
4 0
Business
Impact: Mankind Pharma is an existing investor; its stake may be affected by valuation changes.
Jul 30, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Mankind Pharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.